NSE: ONESOURCE · Pharmaceuticals & Biotechnology

Is OneSource Specialty Pharma safe?

OneSource Specialty Pharma is rated High Risk on Stockfame's red-flag screen (score 13/100): 1 critical, 2 major and 1 minor flags across 12 checks.

+ Add to watchlist Data as of 18 Nov 2026 · NSE filings & annual results
13/100
High Risk

Serious red flag in the filings

1 critical2 major1 minor8 OK
🔒

See the full red-flag report for OneSource Specialty Pharma

Create a free account to unlock all 14 checks — promoter pledging & selling, earnings quality, debt, governance and surveillance — with the evidence and links to the exchange filings.

  • Every flag explained in plain English
  • Evidence with NSE filing links
  • Save stocks to your watchlist

Already a member? Enter your number to log in.

By continuing you agree to our Terms and Privacy Policy.

Questions about OneSource Specialty Pharma

Is OneSource Specialty Pharma stock safe to invest in?

OneSource Specialty Pharma is rated High Risk on Stockfame's red-flag screen (score 13/100): 1 critical, 2 major and 1 minor flags across 12 checks. This is an educational screen of public filings, not investment advice.

This page is an automated, rule-based screen of public disclosures for educational purposes. It is not a recommendation to buy, sell or hold. Methodology.